MRI detection of oncogenic
advanced PET
MRI probes
temporal changes
imaging methods
dual-modality PET
targeted annotation of oncogenic
understanding of cancer
new chemistry
new technologies
new opportunity
efficient methods
various cancers
treatment
generation of anti-cancer therapies
Magnetic Resonance Imaging
underlying biochemistry of cancer control disease progression
hybrid imaging protocols
multi-modality nanomedicines
interdisciplinary ERC Project
personalised clinical management of cancer patients
pathways Spatial
utility of radiolabelled nanomedicines
Positron Emission Tomography
recent introduction of tools
response
anatomic information available
scope
advantage
potential
resistance
early stage
scanners
medical application of nanotechnology
light
work
Successful completion
processes
long-term goals